Tiny Singapore risks economic gloom without big baby boom

File photo shows babies lying in cots at a maternity ward in SingaporeSINGAPORE (Reuters) – History suggests Singapore will enjoy a welcome baby boom in this Year of the Dragon, the most auspicious for births in the Chinese zodiac. But after 25 years of state-sponsored matchmaking and fertility-boosting campaigns, the government's attempts to arrest a sliding birth rate are falling flat, with potentially profound consequences for the wealthy Asian city-state. The calls to conception are now urgent and constant to citizens whose fertility ranks last among 222 nations in the U.S. Central Intelligence Agency's World Factbook. …

Mercury, oils from fish at odds in heart health

NEW YORK (Reuters Health) – Mercury and omega-3 fatty acids – both found in fish – appear to have opposite links to heart health, scientists have found. In an analysis of more than 1,600 men from Sweden and Finland, researchers found that men with high levels of mercury in the body had an increased risk of heart attacks, while those with a high concentration of omega-3s had a lower risk. Fish are considered part of a healthy diet, but the balance between potential risks and benefits from the two compounds is not clear. …

Phone therapy helps some with marijuana dependence

A young man smokes marijuana before the 10th annual Marijuana March in downtown TorontoNEW YORK (Reuters Health) – Telephone therapy may help people dependent on marijuana kick the habit, a new study from Australia suggests. Researchers found that almost twice as many users significantly cut back on marijuana following four hour-long phone counseling sessions compared to those who were put on a treatment waiting list. Knowing therapy may work over the phone could help extend treatment to people in remote areas where in-person therapy is hard to come by, according to Peter Gates, from the University of New South Wales, and his colleagues. …

FDA approves Ironwood constipation drug

(Reuters) – The Food and Drug Administration on Thursday approved Ironwood Pharmaceuticals Inc’s drug to treat chronic constipation and irritable bowel syndrome with constipation for use in adults. The drug, linaclotide, will be sold under the brand name Linzess and carry a boxed warning that it should not be used in patients 16 or younger, the agency said. An estimated 63 million people suffer from chronic constipation, according to the National Institutes of Health. Additionally, an estimated 15. …

Tiny Batteries Are Big Problems for Kids

The small coin-sized batteries found in many toys, electronics and singing greeting cards could be life-threatening in children. An analysis released today by the Centers for Disease Control and Prevention and the Consumer Product Safety Commission found 14 children who are aged 13 and under…

1 6 7 8 9 10 106